Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMITRIPTYLINE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 14 adverse event reports in the FDA FAERS database where AMITRIPTYLINE was used for Psoriasis.

Most Reported Side Effects for AMITRIPTYLINE

Side Effect Reports % Deaths Hosp.
Toxicity to various agents 3,001 14.7% 1,724 1,288
Drug ineffective 2,344 11.5% 59 525
Completed suicide 1,678 8.2% 1,672 446
Off label use 1,588 7.8% 72 435
Pain 1,300 6.4% 71 690
Fall 1,216 6.0% 31 943
Hypotension 1,205 5.9% 103 984
Drug abuse 1,116 5.5% 674 300
Dizziness 1,041 5.1% 77 339
Constipation 1,035 5.1% 17 696
Nausea 1,018 5.0% 40 305
Fatigue 1,014 5.0% 50 296
Overdose 1,009 5.0% 327 606
Sedation 975 4.8% 37 567
Product use in unapproved indication 868 4.3% 27 229

Other Indications for AMITRIPTYLINE

Product used for unknown indication (9,543) Depression (1,410) Pain (752) Neuralgia (651) Migraine (619) Insomnia (614) Sleep disorder (232) Fibromyalgia (224) Headache (220) Migraine prophylaxis (185)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

AMITRIPTYLINE Full Profile All Psoriasis Drugs AMITRIPTYLINE Demographics AMITRIPTYLINE Timeline